Company attributes
B2X
Founder
AngelList URL
Pitchbook URL
Number of Employees (Ranges)
201 – 500
Email Address
investor_relations@merck.com0
mediarelations@merck.com0
Full Address
126 East Lincoln Avenue P.O. Box 2000 Rahway, NJ 07065 USA0
CIK Number
Place of Incorporation
Investors
DUNS Number
1448149310
Founded Date
2003
0Total Funding Amount (USD)
149,900,000
Latest Funding Round Date
September 2013
Competitors
Stock Symbol
XLRN0
Exchange
Acquisition Transaction
Latest Funding Type
CAGE Code
623P90
Patents Assigned (Count)
133
Legal Entity Identifier
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
SIC Code
2,8360
Ticker Symbol
XLRN
Wikidata ID
Acceleron Pharma is focused on harnessing the power of the TGF-beta superfamily, the target-rich biology behind the body’s remarkable capacity for cellular growth and repair. The company's protein engineering capabilities enable them design candidates for serious and rare pulmonary and hematologic diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
